Quilt Health Secures $6M Seed to Expand Access
Slice of Healthcare Team
06/19/2025
Key highlights
- $6M seed funding round closed, total funding now $8M
- Led by MaC Venture Capital and Underscore VC, joined by Meridian Street Capital, BoxGroup, Watershed VC, and Coalition Operators
- Focus on sickle cell disease with plans to expand to neurological, hematologic, and cardiovascular disorders
- AI-powered platform integrates clinical data and workflows to improve trial recruitment and patient retention
- New partnership with National Alliance of Sickle Cell Centers (NASCC) gives access to 115+ U.S. sickle cell centers
Source: Newswire
Notable Quotes
“ Together, we are creating a more effective, national, patient-centered ecosystem that speeds up the path to market for life-saving treatments. ”
Andy Ellner, Founder and CEO at Quilt Health
“ By matching a purpose built technology solution with the needs of a network of world-class sickle cell centers... we will drive towards improving the quality of care and access to care. ”
Julie Kanter, Founder and President at NASCC
“ Quilt is not just improving healthcare efficiency but reshaping the entire landscape of rare disease research. ”
Marlon Nichols, Managing Partner at MaC Venture Capital
Why This Matters
Quilt Health is tackling a foundational flaw in clinical research—patient recruitment and retention—which causes the majority of trials to underperform. With its technology-driven, patient-centered model, Quilt not only bridges the gap between care and research but also brings underserved regions into focus. Its partnership with NASCC and a strategic infusion of $6 million positions the company to scale rapidly, making clinical trials more inclusive and efficient for complex diseases like sickle cell. This is a significant leap toward equity in clinical research and faster delivery of life-saving therapies.
